Successful challenge with the fully human EGFR antibody panitumumab following an infusion reaction with the chimeric EGFR antibody cetuximab.

Source:http://linkedlifedata.com/resource/pubmed/id/17488734

Download in:

View as

General Info

PMID
17488734